Sodexo S.A. (SW.PA) Bundle
Sodexo's latest results deserve a close look: Fiscal 2025 consolidated revenues reached €24.1 billion (+1.2% y/y) driven by 3.3% organic growth (or 3.7% excluding major 2024 event effects), while management now guides Fiscal 2026 organic growth to a slower 1.5-2.5% as U.S. headwinds bite; profitability shows an underlying operating profit of €1,139 million with a 4.7% underlying operating margin and underlying group net profit of €785 million, liquidity and solvency remain intact with net debt at €2.7 billion (net debt/EBITDA 1.8x), gross debt of €4.836 billion (94% fixed, average maturity 2.8 years), operating cash of €1.42 billion and unused credit lines of €1.75 billion, and shareholders get a proposed dividend of €2.70 per share-read on to unpack regional dynamics, margin drivers, balance-sheet resilience, valuation implications and the key risks shaping Sodexo's outlook
Sodexo S.A. (SW.PA) Revenue Analysis
Fiscal 2025 consolidated revenues reached €24.1 billion, up 1.2% year-on-year. Growth was driven by organic expansion of 3.3%, partially offset by a negative currency impact of 1.8% and a net contribution from acquisitions and disposals of +0.3%. Organic growth, excluding the base effects of the Olympics, Rugby World Cup and the leap year in Fiscal 2024, was 3.7%.- Pricing contributed approximately +3.0% to organic growth.
- Volume and net new business added a small positive contribution to organic growth.
- Currency translation subtracted about 1.8 percentage points from reported revenue growth.
| Metric | Amount / Rate |
|---|---|
| Total consolidated revenues (Fiscal 2025) | €24.1 billion |
| Reported YoY growth | +1.2% |
| Organic growth | +3.3% (3.7% ex-base effects) |
| Currency impact | -1.8% |
| Net M&A (acquisitions & disposals) | +0.3% |
| Pricing contribution | ~+3.0% |
- North America: +2.8% organic growth - strong Sodexo Live! and Business & Administration, solid Healthcare underlying momentum despite timing effects, partially offset by Education contract losses.
- Europe: +2.1% organic growth - good Healthcare & Seniors performance; Facilities Management remains soft.
- Rest of the World: +6.6% organic growth - robust growth in Australia, India and Brazil.
- Fiscal 2026 organic revenue growth guidance: 1.5%-2.5% (revised down from 3%-4%).
- Primary headwind: challenges in U.S. operations, which account for roughly 50% of group revenue, reducing near-term growth visibility.
Sodexo S.A. (SW.PA) - Profitability Metrics
Sodexo reported steady improvement in core profitability for the period, with underlying operating profit and margins moving higher on a constant currency basis and underlying net income rising. The following highlights capture the primary profitability drivers and management guidance updates.- Underlying operating profit: €1,139 million, +2.7% year-on-year; +5.0% at constant currencies.
- Underlying operating profit margin: 4.7%, up 10 basis points at constant currencies.
- Underlying group net profit: €785 million, +3.7% at constant currencies.
- Effective tax rate: 22.2%, reflecting tax audit updates and recognition of previously unrecognized French tax losses.
- Dividend proposal: €2.70 per share, aligned with a 50% pay-out ratio on underlying net income.
- Fiscal 2025 underlying operating profit margin guidance: revised to +10-20 basis points at constant currencies (previously +30-40 bps).
| Metric | Reported Value | YoY Change | Change at Constant Currencies |
|---|---|---|---|
| Underlying operating profit | €1,139m | +2.7% | +5.0% |
| Underlying operating profit margin | 4.7% | - | +10 bps |
| Underlying group net profit | €785m | - | +3.7% |
| Effective tax rate | 22.2% | - | - |
| Dividend per share (proposed) | €2.70 | - | - |
| Fiscal 2025 margin improvement guidance | +10-20 bps (constant currencies) | Revised from +30-40 bps | - |
Sodexo S.A. (SW.PA) - Debt vs. Equity Structure
Sodexo S.A. enters the 2025 financial year with a conservative leverage profile and strong liquidity buffers while absorbing an exceptional tax outflow that slightly increased net leverage.
- Net debt: €2.7 billion (up from €2.6 billion at end of Fiscal 2024, primarily driven by an exceptional tax outflow).
- Net debt / EBITDA: 1.8x (versus 1.7x at end of Fiscal 2024), inside the Group's target range of 1-2x.
- Operating cash: €1.42 billion.
- Unused committed credit lines: €1.75 billion (5‑year maturity, renewed in August 2024).
| Item | Value |
|---|---|
| Gross debt | €4.836 billion |
| Net debt | €2.7 billion |
| Net debt / EBITDA | 1.8x |
| Average bond interest rate | 1.8% |
| Average debt maturity | 2.8 years |
| Fixed-rate portion | 94% |
| Covenant status | 100% covenant-free |
| Operating cash | €1.42 billion |
| Unused credit lines | €1.75 billion (5-year) |
Currency composition of gross debt:
- Euro-denominated: 69%
- U.S. dollar-denominated: 25%
- Sterling-denominated: 6%
Key considerations for investors:
- Leverage is modest and within target (1-2x), providing headroom for strategic investments or M&A while maintaining rating-friendly metrics.
- High fixed-rate coverage (94%) limits immediate refinancing/interest-rate volatility risk.
- Solid liquidity position - €1.42bn cash plus €1.75bn committed lines - supports near-term obligations and covenant-free gross debt reduces refinancing constraints.
- Average maturity of 2.8 years concentrates upcoming refinancings in the medium term; currency mix leaves some U.S. dollar and sterling exposure.
For broader context on the company's strategy and capital allocation framework, see Sodexo S.A.: History, Ownership, Mission, How It Works & Makes Money
Sodexo S.A. (SW.PA) - Liquidity and Solvency
Sodexo reported solid free cash flow while maintaining a conservative balance-sheet profile and ready access to committed liquidity. Key headline metrics show a company within its target leverage range and with meaningful buffer for operational and market stress.- Net debt to EBITDA: 1.8x (within target range of 1-2x)
- Operating cash flow: €1.42 billion
- Gross debt: €4.836 billion
- Average interest rate on bonds: 1.8% (stable versus end‑August 2024)
| Metric | Value | Notes |
|---|---|---|
| Net debt / EBITDA | 1.8x | Inside target range (1-2x) |
| Operating cash | €1.42 bn | Operating cash generation during reporting period |
| Free cash flow | Solid (reported) | Management highlighted strong FCF conversion; see full report for absolute figure |
| Gross debt | €4.836 bn | Average maturity 2.8 years |
| Debt structure | 94% fixed rate; 100% covenant-free | Low refinancing risk from covenants |
| Unused committed credit lines | €1.75 bn | 5‑year facility renewed August 2024 |
| Average bond interest rate | 1.8% | Stable vs end‑Aug‑2024 |
- Liquidity cushion: €1.75 billion of unused committed lines (5-year maturity) plus available cash and operating cash flows.
- Interest expense profile: low average bond rate (1.8%) and high share of fixed-rate debt reduce short-term rate exposure.
- Leverage discipline: net debt/EBITDA at 1.8x aligns with stated 1-2x target, supporting investment-grade-like flexibility.
Sodexo S.A. (SW.PA) - Valuation Analysis
Sodexo's capital structure and cash-return policy signal a conservative, investor-friendly stance. Key metrics from the latest reporting period provide a clear frame for valuation multiples, leverage assessment and yield expectations.- Proposed dividend: €2.70 per share (50% pay-out ratio on underlying net income).
- Net debt / EBITDA: 1.8x (vs. 1.7x at end of FY2024), within target range of 1-2x.
- Operating cash flow: €1.42 billion.
- Unused committed credit lines: €1.75 billion (5-year maturity; renewed August 2024).
- Average bond interest rate: 1.8% (stable vs. end-August 2024).
- Gross debt: €4.836 billion - average maturity 2.8 years, 94% fixed-rate, 100% covenant-free.
| Metric | Value | Context/Notes |
|---|---|---|
| Dividend per share | €2.70 | 50% payout of underlying net income (Group policy) |
| Net debt / EBITDA | 1.8x | Target range: 1-2x; prior FY end: 1.7x |
| Operating cash flow | €1.42 billion | Cash generation supporting dividends and deleveraging |
| Unused credit facilities | €1.75 billion | 5-year maturity; renewed Aug 2024 |
| Gross debt | €4.836 billion | Average maturity 2.8 years; 94% fixed; covenant-free |
| Average bond rate | 1.8% | Stable vs. end-Aug 2024 |
Sodexo S.A. (SW.PA) - Risk Factors
Sodexo S.A. (SW.PA) has flagged several material downside risks that investors should weigh alongside valuation and cash‑flow metrics. Management now projects Fiscal 2026 organic revenue growth of 1.5%-2.5% (revised down from 3%-4%), driven largely by soft performance in its U.S. business, which contributes roughly half of group revenue.- U.S. exposure: ~50% of group revenue concentrated in North America; slowdown in the region is the primary driver of the guidance cut.
- Education segment weakness: management attributes recent underperformance to lower-than-expected university enrollments, notably in the U.S. Northeast and Midwest, compressing foodservices and on‑campus spend.
- Healthcare and education concentration: these end markets represent a significant share of North American operations and therefore amplify regional headwinds.
- Policy risk: potential reductions in U.S. federal aid and subsidies could directly affect demand for education and healthcare contracts.
- Inflation and input cost pressures: while tariffs are not expected to cause direct revenue loss, rising costs - especially food imports from Mexico and Canada - may inflate margin pressure.
- Recent profit warning: the company issued a profit warning in March citing weak regional performance, underscoring execution and demand risks in key markets.
| Risk | Driver | Near‑term Impact | Likelihood (management view) |
|---|---|---|---|
| Slower organic growth | U.S. operational weakness | Guidance cut to 1.5%-2.5% for FY26 | High |
| Education downturn | Lower university enrollments (NE & MW) | Reduced foodservice volumes & contract margins | Medium-High |
| Policy & subsidy reductions | U.S. federal aid changes | Potential contract revenue declines in education/healthcare | Medium |
| Input cost inflation | Food import price rises from Mexico/Canada | Margin compression if not passed to clients | Medium |
| Regional concentration | ~50% revenue from North America | Group results highly sensitive to NA trends | High |
- Investor implications: higher short‑term earnings volatility, increased sensitivity to U.S. macro and policy moves, and the need to monitor enrollment trends and contract renewals in education and healthcare.
- Key data points to watch: updated organic growth guidance, quarterly margin progression in North America, enrollment statistics from major U.S. universities, and any U.S. federal aid/subsidy policy changes.
Sodexo S.A. (SW.PA) Growth Opportunities
Sodexo's near-term growth outlook has moderated materially, driven mainly by U.S. market headwinds and softer education demand. Management now forecasts much slower organic revenue growth for Fiscal 2026 and has signaled a number of region- and segment-level risks that will shape investor expectations.- Fiscal 2026 organic revenue growth guidance: 1.5%-2.5% (revised down from prior 3%-4%).
- U.S. exposure: roughly 50% of group revenue is generated in the United States, amplifying U.S.-specific risks.
- Education segment: notable downturn tied to weaker-than-expected university enrollments in the U.S. Northeast and Midwest.
- Profit warning: company issued a profit warning in March, citing weak regional performance (primarily North America).
| Metric | Value / Note |
|---|---|
| Fiscal 2026 organic growth guidance | 1.5% - 2.5% |
| Prior guidance (comparison) | 3% - 4% |
| Share of revenue from U.S. | ≈50% |
| Key challenged segments (North America) | Education, Healthcare |
| Recent corporate action | March profit warning due to weak regional performance |
| Tariff impact | No direct revenue impact expected; potential inflationary pressures on food imports from Mexico & Canada |
| Policy risk | Potential negative effects from reductions in U.S. federal aid/subsidies to education and healthcare |
- U.S. enrollment trends and state/federal funding for education and healthcare - reductions could materially affect demand for campus and healthcare services.
- Regional recovery in North America - timing and magnitude of stabilization in the education and healthcare verticals will dictate near-term performance.
- Cost pressures from imported food inflation - even absent direct tariff impact, rising input costs (Mexico/Canada imports) can compress margins.
- Operational remediation following the March profit warning - management's ability to arrest underperformance and restore prior growth cadence.
Sodexo S.A. (SW.PA) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.